首页> 美国卫生研究院文献>International Journal of Clinical and Experimental Pathology >Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma
【2h】

Cytokeratin positivity in anaplastic large cell lymphoma: a potential diagnostic pitfall in misdiagnosis of metastatic carcinoma

机译:间变性大细胞淋巴瘤中细胞角蛋白阳性:转移性癌症误诊的潜在诊断陷阱

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cytokeratin (pan) and epithelial membrane antigen (EMA) were considered as commonly useful epithelial markers to distinguish cancer from lymphoma, but the expression of cytokeratin (pan) and EMA had also been seen in some lymphomas. Here, we presented an unusual case of anaplastic large cell lymphoma (ALCL) absence of some lymphoid markers (Including CD3, CD20, Pax-5, CD45Ro) and positive for cytokeratin (pan) and EMA, which was misdiagnosed as metastatic carcinoma. Our case suggested that the epithelial markers (including cytokeratin and EMA) show an overlap with that of ALCL, which represented a diagnostic pitfall for confusing ALCL with metastatic carcinoma.
机译:细胞角蛋白(pan)和上皮膜抗原(EMA)被认为是区分癌症和淋巴瘤的常用上皮标记,但是在某些淋巴瘤中也可以看到细胞角蛋白(pan)和EMA的表达。在这里,我们介绍了一个罕见的间变性大细胞淋巴瘤(ALCL)病例,其中缺少一些淋巴样标记物(包括CD3,CD20,Pax-5,CD45Ro),并且细胞角蛋白(pan)和EMA阳性,被误诊为转移性癌。我们的病例表明,上皮标记物(包括细胞角蛋白和EMA)与ALCL重叠,这是将ALCL与转移性癌混淆的诊断陷阱。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号